do glp 1 agonists have cardiovascular benefit GLP-1 receptor and outcome trials: An update A Comprehensive Review of the
Description
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
Girardi, A
Protocol 2 was a single trial in a target population of patients with a pre-existing SUD, assessing the outcome of adverse SUD related clinical events
This is particularly important for those who struggle with overeating due to constant hunger or cravings
Data & Comments Data Views Downloads Citations Comments 2 Comments Comments must be written in English
We retrospectively follow the patients for 7 years after the initiation of treatment
